Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


02.04.2018

1 Ann Surg Oncol
5 Anticancer Res
4 BMC Cancer
1 Br J Surg
8 Cancer
2 Cancer Lett
1 Clin Cancer Res
1 Dis Colon Rectum
1 Eur J Surg Oncol
1 Gastroenterology
1 Gastrointest Endosc
1 Gut
1 Int J Cancer
4 Int J Colorectal Dis
3 Int J Oncol
4 J Surg Oncol
2 Lancet
3 N Engl J Med
1 PLoS One
3 Proc Natl Acad Sci U S A
1 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. SHIDA D, Yoshida T, Tanabe T, Tsukamoto S, et al
    Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis.
    Ann Surg Oncol. 2018 Mar 23. pii: 10.1245/s10434-018-6436.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. WANG W, Li Y, Chen Y, Chen H, et al
    Ethanolic Extract of Traditional Chinese Medicine (TCM) Gamboge Inhibits Colon Cancer via the Wnt/Beta-Catenin Signaling Pathway in an Orthotopic Mouse Model.
    Anticancer Res. 2018;38:1917-1925.
    PubMed     Text format     Abstract available

  3. LEE JH, Yoon YM, Han YS, Yun CW, et al
    Melatonin Promotes Apoptosis of Oxaliplatin-resistant Colorectal Cancer Cells Through Inhibition of Cellular Prion Protein.
    Anticancer Res. 2018;38:1993-2000.
    PubMed     Text format     Abstract available

  4. LIN KM, Yang MD, Tsai CW, Chang WS, et al
    The Role of MTHFR Genotype in Colorectal Cancer Susceptibility in Taiwan.
    Anticancer Res. 2018;38:2001-2006.
    PubMed     Text format     Abstract available

  5. ISEKI Y, Shibutani M, Maeda K, Nagahara H, et al
    MicroRNA-96 Promotes Tumor Invasion in Colorectal Cancer via RECK.
    Anticancer Res. 2018;38:2031-2035.
    PubMed     Text format     Abstract available

  6. KAWAHARA H, Mouri T, Ishida K, Matsumoto N, et al
    Usefulness of TAS-102 as Third-line Chemotherapy for Metastatic Colorectal Cancer.
    Anticancer Res. 2018;38:2419-2422.
    PubMed     Text format     Abstract available


    BMC Cancer

  7. SHIDA D, Ahiko Y, Tanabe T, Yoshida T, et al
    Shorter survival in adolescent and young adult patients, compared to adult patients, with stage IV colorectal cancer in Japan.
    BMC Cancer. 2018;18:334.
    PubMed     Text format     Abstract available

  8. YOUNG JM, Durcinoska I, DeLoyde K, Solomon MJ, et al
    Patterns of follow up and survivorship care for people with colorectal cancer in new South Wales, Australia: a population-based survey.
    BMC Cancer. 2018;18:339.
    PubMed     Text format     Abstract available

  9. HUANG EY, Chang JC, Chen HH, Hsu CY, et al
    Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages.
    BMC Cancer. 2018;18:321.
    PubMed     Text format     Abstract available

  10. HAMASHIMA C, Sano H
    Association between age factors and strategies for promoting participation in gastric and colorectal cancer screenings.
    BMC Cancer. 2018;18:345.
    PubMed     Text format     Abstract available


    Br J Surg

  11. SHINKINS B, Primrose JN, Pugh SA, Nicholson BD, et al
    Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
    Br J Surg. 2018 Mar 26. doi: 10.1002/bjs.10819.
    PubMed     Text format     Abstract available


    Cancer

  12. TSOH JY, Tong EK, Sy AU, Stewart SL, et al
    Knowledge of colorectal cancer screening guidelines and intention to obtain screening among nonadherent Filipino, Hmong, and Korean Americans.
    Cancer. 2018;124 Suppl 7:1560-1567.
    PubMed     Text format     Abstract available

  13. BLACK DS, Cole SW, Christodoulou G, Figueiredo JC, et al
    Genomic mechanisms of fatigue in survivors of colorectal cancer.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31356.
    PubMed     Text format     Abstract available

  14. POLITE BN, Cipriano-Steffens TM, Hlubocky FJ, Jean-Pierre P, et al
    Association of externalizing religious and spiritual beliefs on stage of colon cancer diagnosis among black and white multicenter urban patient populations.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31351.
    PubMed     Text format     Abstract available

  15. SUN A, Tsoh JY, Tong EK, Cheng J, et al
    A physician-initiated intervention to increase colorectal cancer screening in Chinese patients.
    Cancer. 2018;124 Suppl 7:1568-1575.
    PubMed     Text format     Abstract available

  16. PISHVAIAN MJ, Slack RS, Jiang W, He AR, et al
    A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31309.
    PubMed     Text format     Abstract available

  17. CUARESMA CF, Sy AU, Nguyen TT, Ho RCS, et al
    Results of a lay health education intervention to increase colorectal cancer screening among Filipino Americans: A cluster randomized controlled trial.
    Cancer. 2018;124 Suppl 7:1535-1542.
    PubMed     Text format     Abstract available

  18. SY AU, Lim E, Ka'opua LS, Kataoka-Yahiro M, et al
    Colorectal cancer screening prevalence and predictors among Asian American subgroups using Medical Expenditure Panel Survey National Data.
    Cancer. 2018;124 Suppl 7:1543-1551.
    PubMed     Text format     Abstract available

  19. TRAN MT, Jeong MB, Nguyen VV, Sharp MT, et al
    Colorectal cancer beliefs, knowledge, and screening among Filipino, Hmong, and Korean Americans.
    Cancer. 2018;124 Suppl 7:1552-1559.
    PubMed     Text format     Abstract available


    Cancer Lett

  20. JIANG H, Li T, Qu Y, Wang X, et al
    Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression.
    Cancer Lett. 2018 Mar 28. pii: S0304-3835(18)30241.
    PubMed     Text format     Abstract available

  21. LI Y, Oliver PG, Lu W, Pathak V, et al
    Retraction notice to "SRI36160 is a specific inhibitor of Wnt/<beta>-catenin signaling in human pancreatic and colorectal cancer cells" [Canc. Lett. 389C (2017) 41-48].
    Cancer Lett. 2018;422:131.
    PubMed     Text format    


    Clin Cancer Res

  22. TOLEDO RA, Garralda E, Mitsi M, Pons T, et al
    Exome sequencing of plasma DNA portrays the mutation landscape of colorectal cancer and discovers mutated VEGFR2 receptors as modulators of anti-angiogenic therapies.
    Clin Cancer Res. 2018 Mar 27. pii: 1078-0432.CCR-18-0103.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  23. SOLIMAN BG, Karagkounis G, Church JM, Plesec T, et al
    Mucinous Histology Signifies Poor Oncologic Outcome in Young Patients With Colorectal Cancer.
    Dis Colon Rectum. 2018 Mar 23. doi: 10.1097/DCR.0000000000001060.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  24. ZABALETA J, Iida T, Falcoz PE, Salah S, et al
    Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: A history of resected liver metastases worsens the prognosis.
    Eur J Surg Oncol. 2018 Mar 21. pii: S0748-7983(18)30957.
    PubMed     Text format     Abstract available


    Gastroenterology

  25. WEIGL K, Thomsen H, Balavarca Y, Hellwege JN, et al
    Genetic Risk Score is Associated With Prevalence of Advanced Neoplasms in a Colorectal Cancer Screening Population.
    Gastroenterology. 2018 Mar 21. pii: S0016-5085(18)30337.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  26. YABUUCHI Y, Imai K, Hotta K, Ito S, et al
    Higher incidence of metachronous advanced neoplasia in patients with synchronous advanced neoplasia and left-sided colorectal resection for colorectal cancer.
    Gastrointest Endosc. 2018 Mar 21. pii: S0016-5107(18)30215.
    PubMed     Text format     Abstract available


    Gut

  27. JOO JE, Jayasekara H, Wong EM, Clendenning M, et al
    Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort Study.
    Gut. 2018 Mar 24. pii: gutjnl-2018-316122. doi: 10.1136/gutjnl-2018-316122.
    PubMed     Text format    


    Int J Cancer

  28. LI X, Guo X, Li D, Du X, et al
    Multi-regional Sequencing Reveals Intratumor Heterogeneity and Positive Selection of Somatic mtDNA Mutations in Hepatocellular Carcinoma and Colorectal Cancer.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31395.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  29. YDE J, Larsen HM, Laurberg S, Krogh K, et al
    Chronic diarrhoea following surgery for colon cancer-frequency, causes and treatment options.
    Int J Colorectal Dis. 2018 Mar 27. pii: 10.1007/s00384-018-2993.
    PubMed     Text format     Abstract available

  30. KANG SI, Kim DW, Kwak Y, Lee HS, et al
    The prognostic implications of primary tumor location on recurrence in early-stage colorectal cancer with no associated risk factors.
    Int J Colorectal Dis. 2018 Mar 28. pii: 10.1007/s00384-018-3031.
    PubMed     Text format     Abstract available

  31. ETO K, Urashima M, Kosuge M, Ohkuma M, et al
    Standardization of surgical procedures to reduce risk of anastomotic leakage, reoperation, and surgical site infection in colorectal cancer surgery: a retrospective cohort study of 1189 patients.
    Int J Colorectal Dis. 2018 Mar 30. pii: 10.1007/s00384-018-3037.
    PubMed     Text format     Abstract available

  32. CURTIS NJ, West MA, Salib E, Ockrim J, et al
    Time from colorectal cancer diagnosis to laparoscopic curative surgery-is there a safe window for prehabilitation?
    Int J Colorectal Dis. 2018 Mar 25. pii: 10.1007/s00384-018-3016.
    PubMed     Text format     Abstract available


    Int J Oncol

  33. JIN L, Si Y, Hong X, Liu P, et al
    Ethoxysanguinarine inhibits viability and induces apoptosis of colorectal cancer cells by inhibiting CIP2A.
    Int J Oncol. 2018 Mar 16. doi: 10.3892/ijo.2018.4323.
    PubMed     Text format     Abstract available

  34. XIE Y, Liu Y, Li Q, Chen J, et al
    Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer.
    Int J Oncol. 2018 Mar 20. doi: 10.3892/ijo.2018.4328.
    PubMed     Text format     Abstract available

  35. MATSUHASHI N, Takahashi T, Matsui S, Tanahashi T, et al
    A novel therapeutic strategy of personalized medicine based on anti-epidermal growth factor receptor monoclonal antibodies in patients with metastatic colorectal cancer.
    Int J Oncol. 2018 Mar 16. doi: 10.3892/ijo.2018.4322.
    PubMed     Text format     Abstract available


    J Surg Oncol

  36. LEE SY, Kim CH, Kim YJ, Kim HR, et al
    Prognostic significance of the distribution of lymph node metastasis in rectal cancer after neoadjuvant chemoradiation.
    J Surg Oncol. 2018;117:514-522.
    PubMed     Text format     Abstract available

  37. CHEN ST, Wu MC, Hsu TC, Yen DW, et al
    Comparison of outcome and cost among open, laparoscopic, and robotic surgical treatments for rectal cancer: A propensity score matched analysis of nationwide inpatient sample data.
    J Surg Oncol. 2018;117:497-505.
    PubMed     Text format     Abstract available

  38. BAGANTE F, Spolverato G, Beal E, Merath K, et al
    Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer.
    J Surg Oncol. 2018 Mar 25. doi: 10.1002/jso.25044.
    PubMed     Text format     Abstract available

  39. SESHADRI RA, Swaminathan R, Srinivasan A
    Laparoscopic versus open surgery for rectal cancer after neoadjuvant chemoradiation: Long-term outcomes of a propensity score matched study.
    J Surg Oncol. 2018;117:506-513.
    PubMed     Text format     Abstract available


    Lancet

  40. JIA H, Guan Y, Zhu J
    GRECCAR2 trial: details worthy of more attention.
    Lancet. 2018;391:122.
    PubMed     Text format    

  41. RULLIER E, Vendrely V, Denost Q, Asselineau J, et al
    GRECCAR2 trial: details worthy of more attention - Authors' reply.
    Lancet. 2018;391:122-123.
    PubMed     Text format    


    N Engl J Med

  42. LAUBY-SECRETAN B, Vilahur N, Bianchini F, Guha N, et al
    The IARC Perspective on Colorectal Cancer Screening.
    N Engl J Med. 2018 Mar 26. doi: 10.1056/NEJMsr1714643.
    PubMed     Text format    

  43. SCHILSKY RL
    A New IDEA in Adjuvant Chemotherapy for Colon Cancer.
    N Engl J Med. 2018;378:1242-1244.
    PubMed     Text format    

  44. GROTHEY A, Sobrero AF, Shields AF, Yoshino T, et al
    Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
    N Engl J Med. 2018;378:1177-1188.
    PubMed     Text format     Abstract available


    PLoS One

  45. ORTIZ-ORTIZ KJ, Tortolero-Luna G, Rios-Motta R, Veintidos-Feliu A, et al
    Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study.
    PLoS One. 2018;13:e0194415.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  46. LIN YL, Tsai NM, Hsieh CH, Ho SY, et al
    In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway.
    Proc Natl Acad Sci U S A. 2016 Nov 17. pii: 201604752.
    PubMed     Text format     Abstract available

  47. DANILOVA L, Wang H, Sunshine J, Kaunitz GJ, et al
    Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.
    Proc Natl Acad Sci U S A. 2016 Nov 11. pii: 201607836.
    PubMed     Text format     Abstract available

  48. WENTINK MQ, Hackeng TM, Tabruyn SP, Puijk WC, et al
    Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.
    Proc Natl Acad Sci U S A. 2016 Oct 17. pii: 201610258.
    PubMed     Text format     Abstract available


    World J Surg

  49. VAN GRONINGEN JT, Eddes EH, Fabry HFJ, van Tilburg MWA, et al
    Hospital Teaching Status and Patients' Outcomes After Colon Cancer Surgery.
    World J Surg. 2018 Mar 23. pii: 10.1007/s00268-018-4580.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: